Andrew C.

Andrew C. serves as the Chief Commercial Officer at Caidya since July 2022, bringing extensive expertise in business development and leadership from previous roles, including Chief Business Development Officer at Biotaspheric Ltd and Chief Executive Officer at OPTIMAPHARM d.d. Notably, Andrew held positions such as Chief Commercial Officer & EVP Global Business Development at TFS and Chief Executive Officer at Swedish Biomimetics 3000, where responsibilities spanned P&L management and strategic partnerships. With a strong foundation in the pharmaceutical and clinical research sectors, Andrew's career also includes senior leadership roles at ICON plc and Covance. Andrew holds a PhD in Respiratory & Exercise Physiology from Loughborough University.